1 domain / 2 areas / 1 specialization
University of Sydney
Also known as: The University of Sydney
Data updated
The Brain and Mind Centre is advancing psychedelic science with a multidisciplinary focus on developing innovative treatments using AI and preparing for human clinical trials to treat severe mental illness.
Academic Research
0 papersPublished Papers
0
Trial Involvement
4
Distinct Focus Topics
0
Latest Publication
Unknown
Government funding received
1 grantMRFF — MDMA-assisted treatment for PTSD + alcohol use disorder
2022–2027
Lead: Associate Professor Kirsten Morley (University of Sydney) with Monash University team (Dan Lubman, Shalini Arunogiri, Paul Liknaitzky). Part of A$14.8M MRFF clinical-trials package announced January 2022 for combination therapies for mental illness. World-first trial embedding MDMA-assisted, exposure-based treatment within alcohol-treatment services.
SourceQuick Facts
- Type
- academic
- HQ
- Australia
- Website
- Visit
Research Landscape
What the 4 registered trials University of Sydney sponsors or participates in look like when you line them up. Counts come from Blossom’s trial records as of July 2026.
What's live right now, and what stopped?
SourcedRegistry status of all 4 University of Sydney trials Blossom tracks. Orange marks trials recruiting or opening.
Don't read stopped trials as failures: trials end early for funding, recruitment, and strategy reasons too. Status is as last synced from the registry; some 'recruiting' trials may already have finished.